scholarly article | Q13442814 |
P356 | DOI | 10.1038/SREP03979 |
P8608 | Fatcat ID | release_iiebc2gadrefzkbwlsoqg5r3ka |
P932 | PMC publication ID | 3913921 |
P698 | PubMed publication ID | 24496181 |
P5875 | ResearchGate publication ID | 260093506 |
P50 | author | Songjie Cai | Q86127085 |
P2093 | author name string | Qi Zhang | |
Jinhua Xu | |||
Hiroshi Hirano | |||
Masayuki Fujino | |||
Xiao-Kang Li | |||
Yuya Kitajima | |||
Shizue Iwasaki | |||
P2860 | cites work | Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 |
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Regulatory dendritic cells: there is more than just immune activation | Q28388235 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Tolerogenic dendritic cells | Q29618755 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
Dendritic Cell‐Based Immunotherapy for Prostate Cancer | Q34284652 | ||
RNA interference: mechanisms and applications | Q34423362 | ||
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
Tolerogenic dendritic cells and their role in transplantation. | Q35341379 | ||
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs | Q35620073 | ||
Allogeneic transplantation of CD34+ selected hematopoietic cells--clinical problems and current challenges | Q35782528 | ||
TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors | Q36059606 | ||
Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity | Q36106606 | ||
Dendritic cell subsets and type I diabetes: focus upon DC-based therapy | Q36557395 | ||
Generation of large numbers of highly purified dendritic cells from bone marrow progenitor cells after co-culture with syngeneic murine splenocytes | Q36698213 | ||
Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells | Q37417083 | ||
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes | Q37523266 | ||
Origin and development of dendritic cells | Q37700819 | ||
Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival | Q37728582 | ||
iPS cells: a source of cardiac regeneration | Q37805823 | ||
Tolerogenic dendritic cells and their potential applications | Q37826217 | ||
Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells | Q39856765 | ||
Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. | Q41050761 | ||
Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells | Q41447026 | ||
Generation of lymphohematopoietic cells from embryonic stem cells in culture | Q41447884 | ||
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells | Q41684085 | ||
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes | Q42475800 | ||
Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. | Q43638406 | ||
1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta | Q44254558 | ||
Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo | Q44280916 | ||
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
Progress in antisense technology. | Q46033759 | ||
Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells | Q64382101 | ||
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 | ||
Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent | Q73821396 | ||
Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells | Q78447709 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 3979 | |
P577 | publication date | 2014-02-05 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells | |
P478 | volume | 4 |
Q37627785 | Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells |
Q38284706 | Dendritic cell defects in the colorectal cancer |
Q47550123 | Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset |
Q48222588 | Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3. |
Q26750579 | Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy |
Q26799472 | The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases |
Q35675017 | The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity |
Q33659263 | iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells. |
Search more.